Urgent Appeal from International Society for Aerosols in Medicine (ISAM) during COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration

Author/s

Mitchell J.P.,

Berlinski A.,

Canisius S.,

Cipolla D.,

Dolovich M.B.,

Gonda I.,

Hochhaus G.,

Kadrichu N.,

Lyapustina S.,

Mansour H.M.,

Darquenne C.,

Clark A.R.,

Newhouse M.,

Ehrmann S.,

Humphries R.,

Boushey H.

Year

2020

Language

English

Document Type

Letter

Source Title

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Publisher

Mary Ann Liebert Inc.

Download this Publication

Description

[No abstract available]

Theme

Candidate therapeutics and vaccine » Potential therapeutics

Migration angle

Mobility

Region/Country (by coverage)

Global

Index Keywords

clinical decision making; clinical effectiveness; coronavirus disease 2019; drug administration route; government; health care policy; human; infection prevention; infection risk; inhalational drug administration; Letter; medical society; pandemic; patient care; practice guideline; risk benefit analysis; safety; Severe acute respiratory syndrome coronavirus 2; virus transmission; aerosol; Betacoronavirus; Coronavirus infection; decision making; medical society; virus pneumonia; Administration, Inhalation; Aerosols; Betacoronavirus; Coronavirus Infections; Decision Making; Humans; Pandemics; Pneumonia, Viral; Societies, Medical